<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Ras superfamily of <z:chebi fb="0" ids="15996">guanosine-triphosphate</z:chebi> (<z:chebi fb="11" ids="15996">GTP</z:chebi>)-binding proteins regulates a diverse spectrum of intracellular processes involved in <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:mp ids='MP_0003045'>fibrosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Farnesythiosalicylic acid (FTS) is a unique and potent Ras inhibitor which decreased <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:mp ids='MP_0003045'>fibrosis</z:mp> in experimentally induced liver <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> and ameliorated inflammatory processes in <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, <z:mp ids='MP_0006082'>neuritis</z:mp> and <z:hpo ids='HP_0000123'>nephritis</z:hpo> animal models </plain></SENT>
<SENT sid="2" pm="."><plain>FTS effect on Ras expression and activity, muscle strength and <z:mp ids='MP_0003045'>fibrosis</z:mp> was evaluated in the dy(2J)/dy(2J) mouse model of merosin deficient <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The dy(2J)/dy(2J) mice had significantly increased <z:mp ids='MP_0011356'>RAS</z:mp> expression and activity compared with the <z:mp ids='MP_0002169'>wild type</z:mp> mice </plain></SENT>
<SENT sid="4" pm="."><plain>FTS treatment significantly decreased <z:mp ids='MP_0011356'>RAS</z:mp> expression and activity </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, phosphorylation of ERK, a Ras downstream protein, was significantly decreased following FTS treatment in the dy(2J)/dy(2J) mice </plain></SENT>
<SENT sid="6" pm="."><plain>Clinically, FTS treated mice showed significant improvement in hind limb muscle strength measured by electronic grip strength meter </plain></SENT>
<SENT sid="7" pm="."><plain>Significant reduction of <z:mp ids='MP_0003045'>fibrosis</z:mp> was demonstrated in the treated group by quantitative Sirius Red staining and lower muscle collagen content </plain></SENT>
<SENT sid="8" pm="."><plain>FTS effect was associated with significantly inhibition of both MMP-2 and MMP-9 activities </plain></SENT>
<SENT sid="9" pm="."><plain>We conclude that active <z:mp ids='MP_0011356'>RAS</z:mp> inhibition by FTS was associated with attenuated <z:mp ids='MP_0003045'>fibrosis</z:mp> and improved muscle strength in the dy(2J)/dy(2J) mouse model of <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> </plain></SENT>
</text></document>